Dr. Lal PathLabs Ltd. (NSE: LALPATHLAB), one of India’s leading diagnostic chains, has announced a major shareholder reward package, including a 2nd Interim Dividend of ₹7 per share and a 1:1 Bonus Issue for FY 2025-26.
💰 2nd Interim Dividend Details
- The Board of Directors has declared a 2nd Interim Dividend of ₹7 per equity share, representing 70% of the face value of ₹10 per share for the financial year 2025-26.
- Record Date: November 7, 2025
- The dividend will be credited or dispatched within 30 days of its declaration, as per regulatory timelines.
This move underscores the company’s strong cash position and continued focus on delivering value to its shareholders.
🎁 Bonus Share Announcement
- Dr. Lal PathLabs also announced a bonus issue in the ratio of 1:1, meaning investors will receive one additional fully paid-up equity share for every existing share held.
- The record date for determining shareholder eligibility will be announced later.
- The bonus issue remains subject to shareholder and regulatory approvals.
The bonus share issuance is aimed at improving liquidity in the stock and rewarding long-term investors amid steady business growth.
📈 Investor Takeaway
These announcements reflect management confidence in the company’s long-term growth and financial stability. The combination of a solid interim dividend and generous bonus issue positions Dr. Lal PathLabs as one of the more shareholder-friendly companies in the diagnostics sector.
Leave a Reply